Longevity is one of the greatest achievements of our modern era
The data conveyed from the 2016 table below shows a rapidly aging
society in Japan, where the average life expectancy for men and women is
80.98 and 87.14 years respectively＊. On the other hand, there is a rising concern whether or not it is possible to remain in good health while aging.
Naturally, there are individual differences, but the deterioration of a
person’s physical condition and vitality starts from young age. In
addition, the number of people with lifestyle-related diseases, with a
various number of disease diagnosis is increasing around people in their
40s and 50s.
I used to work strenuously in Russia, Japan and many other Asian countries. At that time, I felt confident about my health, but many years of work pressure gradually accumulated stress and chronic fatigue in my body. As a result, I suffered from heart failure and people around me started saying that I would not be able to continue doing business anymore. The doctors prescribed medicines to me, I tried some exercises that included practicing yoga, however, the state of my health was not heading in a good direction.
The first time I heard about mesenchymal stem cells was in 2011, I was talking to a doctor in Russia from the Kremlin Clinic Medical Institution. The doctor told me about Mesenchymal Stem Cell therapy. Initially, I did not have any prior knowledge on stem cells. However, the doctor was very enthusiastic in explaining what stem cells were and he highly recommended I try it for my health. I then visited the institution in Moscow where I learnt about how the stem cells technologies are developed through many years of research. After receiving the Bone Marrow Mesenchymal Stem Cell therapy, my heart failure was healed.
I felt that it was my mission to share this technology with the world. It began in 2011, when our predecessor company in Singapore was established to develop in the Asian market, where the new technology succeeded. In 2014 Kintaro Cells Power Corporation was founded in Tokyo by using the foundation of advanced culture technology. Currently, the culturing technology of KINTARO Cells® is patented in Japan. As a research and development manufacturer, we are continuously developing new enterprises for the future.
＊ Reference: simplified outline of the longevity table from 2016 (Ministry of Health, Labor and Welfare)